Literature DB >> 3087616

Ergotamine tartrate dependency: features and possible mechanisms.

J R Saper, J M Jones.   

Abstract

Based on our clinical experience and the data reviewed and presented in this report, we propose that a state of physical dependency to ergotamine tartrate exists. This dependency state is characterized by the irresistible and dependable use of ergotamine tartrate and is contingent upon a self-sustaining, rhythmic headache/medication cycle that reflects the dependency. The headache and accompaniments (withdrawal headache?) represent the primary withdrawal symptoms. The presence of this state appears to render patients refractory to other forms of preventative therapy, which can be effective only when ergotamine is discontinued and the cycle broken. If the condition is left untreated, it is likely though by no means certain that the more traditional aspects of ergotism will evolve, although variable susceptibility and tolerance to ergotamine tartrate have been demonstrated. The mechanism of this disorder remains uncertain but might be related to the influence of ergotamine tartrate on the limbic-hypothalamic-pituitary-adrenal axis and other aminergic centers (locus ceruleus), areas considered by some as the central loci for the pathogenesis and associated symptoms of migraine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087616     DOI: 10.1097/00002826-198606000-00003

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  16 in total

Review 1.  Dependent behavior in patients with medication-overuse headache.

Authors:  Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  The severity model of chronic headache.

Authors:  M J Smith; N M Jensen
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

3.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

4.  Behavioral management of exercise training in vascular headache patients: an investigation of exercise adherence and headache activity.

Authors:  J M Fitterling; J E Martin; S Gramling; P Cole; M A Milan
Journal:  J Appl Behav Anal       Date:  1988

Review 5.  Vascular headache.

Authors:  K L Kumar; T G Cooney
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

Review 6.  Drug overuse and rebound headache.

Authors:  Stephen D Silberstein; Dongmei Liu
Journal:  Curr Pain Headache Rep       Date:  2002-06

Review 7.  Analgesic rebound headache. How great is the problem and what can be done?

Authors:  S D Silberstein; W B Young
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

8.  Chronic Daily Headache.

Authors:  James R. Couch
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

Review 9.  Headache.

Authors:  N H Raskin
Journal:  West J Med       Date:  1994-09

10.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.